Literature DB >> 31201791

MHC-I peptide binding activity assessed by exchange after cleavage of peptide covalently linked to β2-microglobulin.

Mollie M Jurewicz1, Richard A Willis2, Vasanthi Ramachandiran2, John D Altman3, Lawrence J Stern4.   

Abstract

A common approach to measuring binding constants involves combining receptor and ligand and measuring the distribution of bound and free states after equilibration. For class I major histocompatibility (MHC-I) proteins, which bind short peptides for presentation to T cells, this approach is precluded by instability of peptide-free protein. Here we develop a method wherein a weakly-binding peptide covalently attached to the N-terminus of the MHC-I β2m subunit is released from the peptide binding site after proteolytic cleavage of the linker. The resultant protein is able to bind added peptide. A direct binding assay and method for estimation of peptide binding constant (Kd) are described, in which fluorescence polarization is used to follow peptide binding. A competition binding assay and method for estimation of inhibitor binding constant (Ki) using the same principle also are also described. The method uses a cubic equation to relate observed binding to probe concentration, probe Kd, inhibitor concentration, and inhibitor Ki under general reaction conditions without assumptions relating to relative binding affinities or concentrations. We also delineate advantages of this approach compared to the Cheng-Prusoff and Munson-Rodbard approaches for estimation of Ki using competition binding data.
Copyright © 2019 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Competition assay; Equilibrium binding constant; Fluorescence polarization; IC(50); Major histocompatibility protein; Peptide exchange

Mesh:

Substances:

Year:  2019        PMID: 31201791      PMCID: PMC6760266          DOI: 10.1016/j.ab.2019.05.017

Source DB:  PubMed          Journal:  Anal Biochem        ISSN: 0003-2697            Impact factor:   3.365


  62 in total

1.  A three-step kinetic mechanism for peptide binding to MHC class II proteins.

Authors:  R V Joshi; J A Zarutskie; L J Stern
Journal:  Biochemistry       Date:  2000-04-04       Impact factor: 3.162

2.  A minimal peptide substrate in biotin holoenzyme synthetase-catalyzed biotinylation.

Authors:  D Beckett; E Kovaleva; P J Schatz
Journal:  Protein Sci       Date:  1999-04       Impact factor: 6.725

3.  Empty and peptide-loaded class II major histocompatibility complex proteins produced by expression in Escherichia coli and folding in vitro.

Authors:  M Frayser; A K Sato; L Xu; L J Stern
Journal:  Protein Expr Purif       Date:  1999-02       Impact factor: 1.650

4.  Use of fluorescence polarization to monitor MHC-peptide interactions in solution.

Authors:  S Dédier; S Reinelt; S Rion; G Folkers; D Rognan
Journal:  J Immunol Methods       Date:  2001-09-01       Impact factor: 2.303

5.  Purification of correctly oxidized MHC class I heavy-chain molecules under denaturing conditions: a novel strategy exploiting disulfide assisted protein folding.

Authors:  Henrik Ferré; Emmanuel Ruffet; Thomas Blicher; Christina Sylvester-Hvid; Lise Lotte B Nielsen; Timothy J Hobley; Owen R T Thomas; Søren Buus
Journal:  Protein Sci       Date:  2003-03       Impact factor: 6.725

6.  Competition-based cellular peptide binding assays for 13 prevalent HLA class I alleles using fluorescein-labeled synthetic peptides.

Authors:  Jan H Kessler; Bregje Mommaas; Tuna Mutis; Ivo Huijbers; Debby Vissers; Willemien E Benckhuijsen; Geziena M Th Schreuder; Rienk Offringa; Els Goulmy; Cornelis J M Melief; Sjoerd H van der Burg; Jan W Drijfhout
Journal:  Hum Immunol       Date:  2003-02       Impact factor: 2.850

7.  The human class II MHC protein HLA-DR1 assembles as empty alpha beta heterodimers in the absence of antigenic peptide.

Authors:  L J Stern; D C Wiley
Journal:  Cell       Date:  1992-02-07       Impact factor: 41.582

8.  Immunogenicity of two peptide determinants in the cytolytic T-cell response to flavivirus infection: inverse correlation between peptide affinity for MHC class I and T-cell precursor frequency.

Authors:  M Regner; A Müllbacher; R V Blanden; M Lobigs
Journal:  Viral Immunol       Date:  2001       Impact factor: 2.257

9.  Structure and function in rhodopsin: high-level expression of rhodopsin with restricted and homogeneous N-glycosylation by a tetracycline-inducible N-acetylglucosaminyltransferase I-negative HEK293S stable mammalian cell line.

Authors:  Philip J Reeves; Nico Callewaert; Roland Contreras; H Gobind Khorana
Journal:  Proc Natl Acad Sci U S A       Date:  2002-10-07       Impact factor: 11.205

10.  Establishment of a quantitative ELISA capable of determining peptide - MHC class I interaction.

Authors:  C Sylvester-Hvid; N Kristensen; T Blicher; H Ferré; S L Lauemøller; X A Wolf; K Lamberth; M H Nissen; L Ø Pedersen; S Buus
Journal:  Tissue Antigens       Date:  2002-04
View more
  3 in total

1.  Production of soluble pMHC-I molecules in mammalian cells using the molecular chaperone TAPBPR.

Authors:  Sara M O'Rourke; Giora I Morozov; Jacob T Roberts; Adam W Barb; Nikolaos G Sgourakis
Journal:  Protein Eng Des Sel       Date:  2019-12-31       Impact factor: 1.650

2.  Broadly recognized, cross-reactive SARS-CoV-2 CD4 T cell epitopes are highly conserved across human coronaviruses and presented by common HLA alleles.

Authors:  Aniuska Becerra-Artiles; J Mauricio Calvo-Calle; Mary Dawn Co; Padma P Nanaware; John Cruz; Grant C Weaver; Liying Lu; Catherine Forconi; Robert W Finberg; Ann M Moormann; Lawrence J Stern
Journal:  Cell Rep       Date:  2022-05-27       Impact factor: 9.995

Review 3.  Fluorescence Polarization-Based Bioassays: New Horizons.

Authors:  Olga D Hendrickson; Nadezhda A Taranova; Anatoly V Zherdev; Boris B Dzantiev; Sergei A Eremin
Journal:  Sensors (Basel)       Date:  2020-12-12       Impact factor: 3.576

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.